Lyvgen Biopharma
Manufacturing · China · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Suite 601b Building 8 1043 Ha Lei Rd, Sh...Phone Number
+86 2150663350Website
www.lyvgen.comRevenue
$6.2 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Lyvgen Biopharma
Lyvgen is a biopharmaceutical company focused on developing innovative immuno-oncology therapeutics. Lyvgen was established in 2016, and is headquartered in Shanghai, China.Explore more
Lyvgen Biopharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lyvgen Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Lyvgen Biopharma has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Lyvgen Biopharma has new funding data
Check out if Lyvgen Biopharma is spiking on competitors!
Product Launch: Get notified when Lyvgen Biopharma launches new products
Lyvgen Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Lyvgen Biopharma had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Lyvgen Biopharma recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Lyvgen Biopharma
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Lyvgen Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Lyvgen Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Lyvgen Biopharma.
Lyvgen Biopharma financials insights
Gather financial insights about Lyvgen Biopharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series B
$30M
Lyvgen Biopharma Tech Stack
A closer look at the technologies used by Lyvgen Biopharma
Lyvgen Biopharma News & Media
Lyvgen Biopharma Presents Clinical Trial Data of CD137/4-1BB Agonistic Antibody LVGN6051 at the 2021 ASCO Annual Meeting
SHANGHAI--(BUSINESS WIRE)-- #ASCO--Lvgen Biopharma announces that it will present a Trials in Progress poster presentation at the ASCO to be held from June 4 to 8, 2021.China Digest: IDG Capital backs Lyvgen's Series C; VirtAI Tech bags over $10m
Suzhou Longmen Ventures, Chengwei Chuangban Investment, and FTZ Fund participated in Lyvgen's funding round.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lyvgen Biopharma
Sign Up For FreeTo access detailed company insights
Lyvgen is a biopharmaceutical company focused on developing innovative immuno-oncology therapeutics. Lyvgen was established in 2016, and is headquartered in Shanghai, China.... Read More
